Small Molecules

28 Sep 2007 Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
27 Sep 2007 Ixabepilone in combination with capecitabine extends progression-free survival in metastatic breast cancer by 40% compared to capecitabine alone
27 Sep 2007 InterMune Announces Start of Phase 1b Trial of ITMN-191
27 Sep 2007 CombinatoRx Announces Initiation of Phase 2b Clinical Study of CRx-102 in Knee Osteoarthritis
27 Sep 2007 NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
27 Sep 2007 Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO)
27 Sep 2007 New Preliminary Phase II Data Show Anti-Tumor Activity of Single-Agent Sunitinib Malate in Advanced Gastric Cancer
27 Sep 2007 Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
27 Sep 2007 CollaGenex Pharmaceuticals Announces Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Rosacea
27 Sep 2007 Novacea Initiates Phase 2 Trial of Asentar in Advanced Pancreatic Cancer
27 Sep 2007 Recordati Successfully Ccompletes the Silodosin Double-Blind Phase III Study
27 Sep 2007 Alkermes and Indevus announce positive results form Phase 2a clinical study of Alks 27 for the treatment of COPD
27 Sep 2007 JT and Torii Sign Licensing Agreement with Keryx for Development and Commercialization of Hyperphosphatemia Drug in Japan
27 Sep 2007 ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
26 Sep 2007 Curis Provides Program Update on Development Candidate CUDC-101 and Its Targeted Cancer Drug Development Platform
26 Sep 2007 Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European College of Clinical Oncology Annual (ECCO) Meeting
26 Sep 2007 Orexigen(TM) Announces Positive Clinical Results of Its Proprietary Naltrexone Sustained Release Formulation for Use in Contrave(TM)
26 Sep 2007 Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
26 Sep 2007 Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
26 Sep 2007 Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
26 Sep 2007 Incyte Reports Positive Proof-of-Concept Results For INCB18424, Its Lead JAK Inhibitor, and INCB13739, its Lead 11beta-HSD1 Inhibitor
26 Sep 2007 DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug-Compliant Subjects in Phase Ib Clinical Study
26 Sep 2007 Alpharadin treatment more than doubles survival rate in prostate cancer patients
26 Sep 2007 Results presesented at ECCO 2007 further confirm the clinical efficacy of BioAlliance Pharma's antifungal particularly in populations with high risk of candidiasis
25 Sep 2007 Protherics signs ReGel(TM) licensing agreement with Myungmoon Pharm

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up